Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FR-taVNS Tinnitus Tria

NCT: NCT07711639 · RECRUITING

NCT IDNCT07711639
StatusRECRUITING
Start Date2026-04-28
Completion2028-12-31
SponsorTzu Chi University (OTHER)
First posted
Last updated

Brief Summary

Tinnitus is a common neurosensory symptom affecting 12-30% of adults and is closely associated with anxiety, sleep disturbance, and autonomic dysregulation. Current pharmacologic treatments offer limited efficacy and notable side effects, prompting interest in non-pharmacological approaches. This randomized, single-blind, sham-controlled trial evaluates whether foot reflexology (FR), transcutaneous auricular vagus nerve stimulation (ta-VNS), and auricular acupressure (AA) improve tinnitus severity, psychological distress, sleep quality, and autonomic indicators (heart rate variability and salivary cortisol) in non-cancer adults with tinnitus, compared with usual care. Participants are randomized to a foot reflexology group, an auricular vagus nerve stimulation group (each with true and sham subgroups), or a usual-care control group, and are followed at baseline and weeks 2, 4, and 8.

Frequently Asked Questions

What is FR-taVNS Tinnitus Tria?

FR-taVNS Tinnitus Tria is a clinical trial registered under NCT07711639. Current status: RECRUITING.

What is the status of NCT07711639?

The current status of NCT07711639 (FR-taVNS Tinnitus Tria) is: RECRUITING.

When did FR-taVNS Tinnitus Tria start?

FR-taVNS Tinnitus Tria started on 2026-04-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.